Plant-Based Biologics Market Latest Report with Forecast to 2028
The acquisition was worth USD 85 million and it clearly improves the market share and penetration of Denka which can further solidify its position as it can now focus on vaccines and diagnostics reagents, in order to develop new biopharmaceuticals.
View full press release